| Literature DB >> 35733526 |
Selvakumari Ulagesan1, Sathish Krishnan2, Taek-Jeong Nam3, Youn-Hee Choi1,3.
Abstract
Oysters are saltwater bivalves with high nutritional and medicinal value that are consumed widely around the world. As well as being highly nutritious, oysters are a low-calorie, low-cholesterol source of protein and an exceptional source of zinc, which strengthens the immune system; and a rich source of bioactive compounds, which comprise various biological activities. The present review summarizes the biological applications and bioactive compounds from oyster shells, whole tissue, gill tissue, and mantle tissue. The various biological compounds present in an oyster shell, and their chemical constituents, have applications in the food, pharmaceutical, and medical industries. Bioactive peptides and proteins obtained from the whole, mantle, and gill tissues of oysters exhibit antioxidant, antimicrobial, antihypertensive, anticancer, antifatigue, anticoagulant, and anti-wrinkle effects, as well as enhance osteoblast differentiation. This review clearly shows that oysters have great potential for functional food production and that various compounds therein can have pharmaceutical applications.Entities:
Keywords: bioactive peptides; marine organisms; oyster; oyster peptide; oyster shell; protein hydrolysates; the biocidal activity of oyster
Year: 2022 PMID: 35733526 PMCID: PMC9208005 DOI: 10.3389/fbioe.2022.913839
Source DB: PubMed Journal: Front Bioeng Biotechnol ISSN: 2296-4185
FIGURE 1Schematic representation of Bioactive compounds derived from different parts of oyster such as shell, whole tissue, gill tissue and mantle tissue and their biological activities.
FIGURE 2Schematic representation of Preparation and applications of Bioactive peptides from oyster tissue and shell.
Bioactive compounds derived from oyster shell and their biological applications.
| Species | Application | Bioactive compound | Results | References |
|---|---|---|---|---|
| Oyster | Antimicrobial activity | Calcined shell powder | Suppressing the growth of |
|
| Oyster | 0.05% of Shell powder | Improving the quality of kimchi by reducing the growth of aerobic bacteria and increasing lactic bacteria |
| |
| Oyster | 0.05–0.2% of shell powder | Reducing he micobial number and increase the self life of tofu |
| |
| Oyster | Shell powder additives | Reducing the microbial number and prolonged the and quality of Gat kimchi |
| |
| Oyster | Heat trated calcined oyster shell (CaO) and non-calined oyster shell | Calcined shellpowder showed biocidal activity against the |
| |
| Oyster | Calcined shell powder | Inhibited the microbial growth and increased the self life of pork ham |
| |
| Oyster | Calcined shell powder | Inhibited the food borne disease microorganisms ( |
| |
|
| ||||
| Oyster | Propylene film with calcined shell powder | Enhanced antimicrobial efficiency without cytotoxicity |
| |
| Oyster | Anti-inflammatory activity | Oyster shell extract | Suppressed the NO production, decreased the expression of the oyster iNOS, COX-2 and NF-κB and inhibites the production of IL-1β, IL-6, and TNF-α in LPS stimulated Raw 264.7 cells |
|
| Oyster | Bone tissue bioengineering | Nacre as bone graft sustituion | Narce binds directely with newly formed bone without any fiborous tissue formation |
|
| Oyster | Molecules of nacre | Activates the osteogenesis in bone marrow cells |
| |
|
| Water soluble matrix protein (WSMP) | Identified protein with osteogenic activity which are responsible for the bone remodelling and biocompatibility |
| |
| Oyster | Nacre powder | osteogenic differentiation of human bone marrow mesenchymal stem cells |
| |
| Oyster | Nacre particle and its soluble protein matrix | Induce the differentation in human bone cells (osteoinductive capacity) |
| |
|
| Anti-osteooresis activity | WSMP | Promote the osteogenesis and inhibits osteoclast absorption |
|
| Oyster | Anti-fibrotic activity | Shell extract | Enhances the catabolic pathway of human dermal fibroblasts | |
| Oyster | Lipogenesis inhibition | Oyster shell extract | lipid-lowering effect | Khoi et al., 2015 |
| Oyster | Environmental application | Oyster shell | Used to remove pollutants, organics, neurotoxin and nitrogen | Bonnard. 2021 |
| Oyster | Environmental application | Oyster shell powder | Mitigate the harmful algal bloom by reducing phosphate, nitrogen and COD |
|
Antioxidant peptides derived from oyster whole tissue.
| Species | Enzyme used | Oyster peptides and/or MW | Results | References |
|---|---|---|---|---|
|
| Pepsin, trypsin, α-chymotrypsin | LKQELEDLLEKQE (1600 Da) | Scavenged cellular radicals and protective effect on hydroxyl radicals generated DNA damage |
|
|
| papain, neutrase, and alcalase | (<1 kDa) | Alcalase derived hydrolysates showed the strongest overall antioxidant activity |
|
|
| neutral proteinase | scavenging effects against the hydroxyl radicals |
| |
| DPPH, and superoxide anion radicals | ||||
|
| Protease | SCAP 1–7 | Peptides (SCAP 1, 3, and 7) had the highest scavenging ability on DPPH radicals |
|
|
| Subtilisin | PVMGA (518 Da) and QHGV | DPPH and hydroxyl radical scavenging activity |
|
|
| Food grade proteases, alcalase, bromelin, and neutral protease | Alcalase derived hydrolysates showed the maximum scavenging asainst DPPH and hydroxyl radicles |
| |
|
| Papain | ISIGGQPAGRIVM (1297.72 Da) | DPPH and hydroxyl radical-scavenging activity, |
|
| Ferric reducing and iron chelating activity and lipid peroxidation inhibition | ||||
|
| Protease | (<6 kDa) | ABTS and DPPH radical-scavenging activity oxygen radical absorbance capacity (ORAC) and cellular antioxidant activity (CAA) in a HepG2 cells |
|
| oyster | Protamex, Neutrase | YA | Dose dependent DPPH and ABTS radical scavenging activity |
|
| Microbial transglutaminase | ||||
|
|
| Alcalase |
|
|
| and the T-AOC levels and reduced MDA level | ||||
|
| Trypsin | PVMGA (518 Da), QHGV (440 Da) | DPPH and hydroxyl radical-scavenging activity |
|
|
| Pepsin, trypsin, Maxipro PSP | PEP-1, PEP-2, TRYP-2, and MIX-2 | DPPH and hydroxyl radical-scavenging activity |
|
Antimicrobial peptide derived from oyster whole Tissue.
| Species | Name of AMP | Enzyme used | Oyster peptides and/or MW | Results | References |
|---|---|---|---|---|---|
|
| Thermolysin | LLEYSI, LLEYSL | Inhibit the HIV-1 protease |
| |
|
| Plasma peptides | (<10 kDa) | Against the Gram-positive bacteria ( |
| |
|
| SPE | Cytotoxic activity against vero cells |
| ||
|
| Cg-Defh1 and Cg-Defh2 | GFGCPRDQYKCNSHCQSIGCRAGYCDAVTLWLRCTCTDCNGKK and GFGCPGDQYECNRHCRSIGCRAGYCDAVTLWLRCTCTGCSGKK | Recombinant AMP’s based on prokaryotic expression of |
| |
|
| CgPep33 | Alcalase | Antifungul activity against |
| |
|
| CgPep33 | Alcalase | Antibacterial activity against Gram-positive bacteria ( |
| |
|
| Cg-Prp | Alcalase | ILENLLARSTNEDREGSIFDTGPIRRPKPRPRPRPEG | Against Gram-positive bacteria ( |
|
|
| Cg-BigDef1 | QAQALLPIASYAGLTVSAPVFAALVTVYGAYALYRYNIRRRENSYQRIRSDHDSHSCANNRGWCRPTCFSHEYTDWFNNDVCGSYRCCRPGRSG (10.7 kDa) | Against gram positive and negative bacteria |
| |
| Cg-BigDef1 | QAQALLPIASYAGLAVSPPVFAALVTAYGVYALYRYNIRRENSDHDSHSCANNRGWCRPTCYSYEYTDWFNNDVCGSYRCCRPGRRG | ||||
| Cg-BigDef1 | QAQILLPIASYAGLTVTAPVFAALVAAYGIYAVTRYAIRKRRIVMYSDSHSCANNRGWCRESCFSHEYTDWANTFGVCGSYFCCRPY | ||||
|
| cgTβ | Trypsin | (4656.4 Da) | Against Gram-positive bacteria ( |
|
| 1021) and Gram-negative bacteria ( | |||||
|
| Alcalase, bromelin, neutrase | (6500 Da) | Against Gram-positive bacteria ( |
|
Bioactive peptides derived from oyster whole tissue.
| Biological activity | Species | Enzyme used | Oyster peptides and/or MW | Results | References |
|---|---|---|---|---|---|
| Antihypertensive activity |
| Pepsin | VVYPWTQRF (1195 Da) | ACE inhibitory activity and decrease the systolic blood pressure (SBP) |
|
| Crosse | |||||
|
| (592.9 Da) | ACE-inhibitory activity and decrease the SBP by 12 mmHg after 3 h |
| ||
|
| Trypsin | DLTDY | ACE inhibitory activity and decrease the SBP |
| |
|
| HLHT and GWA | ACE inhibitory activity and efficient antihypertensive effect on SRH rats |
| ||
|
| Pepsin, bromelain, and papain | Higher ACE and DPP-IV activity observed in pepsin hydrolysates |
| ||
| Anti-inflammatory activity |
| Protamex | QCQCAVEGGL | Inhibit NO production in RAW264.7 cells and Decrease and increase the serum IgE and spleen CD4+/CD8+ levels in Male BALB/c mice, respectively |
|
| Microbial transglutaminase, protamex and neutrase | YA | Inhibit NO production in RAW264.7 cells |
| ||
|
| Trypsin | β-thymosin (4656.4 Da) | Inhibits NO production in LPS-induced RAW264.7 cells and PGE2, iNOS and COX-2 expression; Inhibits the inflammatorycytokines (TNF-α, IL-1β, IL-6), repress the nucleartranslocationof phosphorylated nuclear factor-κB and degradation of inhibitor of nuclear factor-κB |
| |
|
| Pepsin | Repress inflammatory cytokines and mediators (TNF-α, IL-1β, IL-6, iNOS) at transcription level in LPS-induced RAW264.7 cells |
| ||
| Anticoagulant activity |
| Pepsin, trypsin papain and nuetral protease | DFEEIPEEYLQ and TARNEANVNIY (1264.36) | Thrombin inhibition including prolonged the activated partial thromboplastin |
|
|
| Pepsin and pancreatin | LSKEEIEEAKEV | Prolong the APTT and TT, inhibit thrombin |
| |
|
| Pepsin | P-3-CG | Prolong the APTT and decrease the mortality in male Kumming mice |
| |
| Anticancer activity |
| Protease | Oligopeptide-enriched hydrolysates (<3 kDa) | Inhibition against the growth of sarcoma-s-180 in BALB/c mice |
|
|
| Flavourzyme | HFNIGNRCLC | Cytotoxicity including apoptosis of prostate, breast, and lung cancer cells but not normal liver cells |
| |
|
| Protease isolated from | LANAK | Activity against the HT-29 cell lines |
| |
| Anti-fatigue |
| Nutrease | prolonged swimming time and incresed glycogen in liver and gastrocnemius muscle; decrease the serum lactic acid and BUN male Kumming mice |
| |
|
| |||||
|
| Compound protease | (<6 kDa) | Increase in exercise tolerance, liver glycogen and muscle glycogen, decrease the levels of BUN in male Kumming mice |
| |
| Nutrease | Prolong the swimming time, increase the levels of liver glycogen, |
| |||
| decrease the levels of lactic acid | |||||
| Anti-wrinkle |
| Protamex, Neutrase and AMG | Anti-melanogenic activities |
| |
| Reproduction enhancing | |||||
| Neutrase, papain, bromelain | (343 Da) | Rats with reproductive dysfunction induced by cyclophosphamide exhibited Increase the level of key regulatory protein expression and androgen in the blood |
| ||
|
| SPE | Cg-GnRH-a (pQNYHFSNGWQPa) and CgGnRH-G (pQNYHFSNGWQPG) | Regulate the neurological and endocrine factors and supports the nutrition and energy demand during reproduction |
| |
|
| Ethanol extract showed the aphrodisiac property |
| |||
| Osteogenic |
| Pepsin, pancreatin | YRGDVVPK (992.40 Da) | Promote the proliferation of MC3T3-E1 cells |
|
|
| Osteoclastogenesis by inactivating the NF-κB-mediated NFATc1 and c-Fos signaling pathways and scavenging the ROS generation in RAW 264.7 Cells | ||||
| Zinc-binding |
| Pepsin | Peptide-zinc complex promoted the intestinal absorption of zinc |
|
Bioactive peptides derived from oyster gill tissue and mantle tissue.
| Biological activity | Species | Enzyme used | Oyster peptides and/or MW | Results | References |
|---|---|---|---|---|---|
| Anti-microbial |
| GFGCPWNRYQCHSHCRSIGRLGGYCAGSLRLTCTCYRS (4265.0 Da) | Against Gram-positive bacteria ( |
| |
| bacteria ( | |||||
|
| Trypsin | cgUbiquitin (8471 Da) | Against Gram-positive bacteria ( |
| |
| (Gill tissue) | |||||
| cgMolluscidin, AATAKKGAKKADAPAKPKKATKPKSPKKAA | Against Gram-positive bacteria ( |
| |||
| KKAGAKKGVKRAGKKGAKKTTKAKK (5.5 kDa) |
| ||||
| AKSKNHTSHNQNRKQHRNGIHRPKTYRYPSMKGVDPKFL KNLKFSKKHNKNTKK(6484.6 Da) | Against Gram-positive bacteria ( |
| |||
| KCTC 1021) and Gram-negative bacteria | |||||
| ( | |||||
|
| Cg-Defm, GFGCPGNQLKCNNHCKSISCRAGYCDAATLWL | Against Gram-positive bacteria ( |
| ||
| (Mantle tissue) | RCTCTDCNGKK |
| |||
|
| |||||
| Osteogenic |
| PFMG4 | Homology with C1q protein in different species, mainly in MC3T3-E1 osteoblast cell |
|